- €879.16m
- €853.05m
- €133.92m
2018 January 31st | 2019 January 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 135 | 139 | 133 | 133 | 134 |
Cost of Revenue | |||||
Gross Profit | 97.8 | 102 | 98.7 | 103 | 106 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 127 | 132 | 129 | 149 | 108 |
Operating Profit | 8.08 | 7.01 | 4.05 | -16.5 | 25.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.58 | 5.84 | 2.43 | -17.3 | 24.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.38 | 3.33 | 1.43 | -18.6 | 15.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.38 | 3.33 | 1.41 | -18.6 | 15.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.38 | 3.33 | 1.41 | -18.6 | 15.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.423 | 0.588 | 0.248 | -3.26 | -0.432 |
Dividends per Share |